Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for AVI Products India's ROE % or its related term are showing as below:
BOM:523896'
s ROE % Range Over the Past 10 Years
Min: -31.93 Med: 4.16 Max: 9.09
Current: -31.93
During the past 13 years, AVI Products India's highest ROE % was 9.09%. The lowest was -31.93%. And the median was 4.16%.
BOM:523896's ROE % is ranked worse than 92.92% of 113
companies
in the Medical Distribution industry
Industry Median: 7.15
vs BOM:523896: -31.93
AVI Products India (BOM:523896) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
AVI Products India ROE % Related Terms
AVI Products India ROE % Historical Data
* Premium members only.
The historical data trend for AVI Products India's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, AVI Products India's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AVI Products India ROE % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, AVI Products India's ROE % distribution charts can be found below:
* The bar in red indicates where AVI Products India's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
AVI Products India (BOM:523896) has a ROE % of -43.92% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on AVI Products India and its competitors. According to the industry distribution chart, AVI Products India ranks #105 out of 113 companies in the Medical Distribution industry, placing it in the top 92.9%.
Is AVI Products India's ROE % too high?
AVI Products India's current ROE % is -43.92%. Based on the distribution chart, AVI Products India ranks #105 out of 113 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, AVI Products India has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AVI Products India's ROE % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, AVI Products India ranks #105 out of 113 companies for ROE %. This places AVI Products India in the lower half of its industry. The industry median ROE % is 7.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Distribution company?
The median ROE % among Medical Distribution companies is 7.15, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on AVI Products India and its competitors. For the Medical Distribution industry, the median ROE % is 7.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AVI Products India's current ROE % is -43.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVI Products India stock overvalued right now?
Based on GuruFocus' analysis, AVI Products India (BOM:523896) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹6.78, compared to a current price of ₹49.91 — trading 636.1% above its estimated fair value. The current ROE % is -43.92%. AVI Products India's overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For AVI Products India (BOM:523896), the current ROE % is -43.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AVI Products India (BOM:523896) Overvalued in 2026?
Based on GuruFocus' analysis, AVI Products India stock appears to be overvalued.
The current stock price of ₹49.91 is trading 636.1% above its estimated GF Value™ of ₹6.78.
GuruFocus considers AVI Products India to be Significantly Overvalued.
Key valuation signals for BOM:523896:
ROE %: -43.92%
GF Value™: ₹6.78 vs. price of ₹49.91 (636.1% above fair value)
No single metric tells the full story. See the BOM:523896 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AVI Products India Ltd is an India-based company that operates in two main segments: E-commerce and Trading, and Food and Beverages. The E-commerce segment distributes dental products like endo-motors, intraoral cameras, curing machines, autoclaves, dental chemicals, and orthodontic materials through Dentaldeal. in. The Food and Beverages segment, under the IFRUIT brand, runs franchises offering ice cream rollies, kulfis, sorbets, sundaes, smoothies, milkshakes, and Belgium waffles. The majority of its revenue comes from e-commerce and Trading.
47GF Score
Get the complete analysis for BOM:523896
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:523896 has been successfully added to your 
